Education
About Us
Working with TipRanks
Follow Us
Oscar Health (OSCR)
NYSE:OSCR
OSCR Analyst Ratings
Moderate Sell
1 Buy
1 Hold
3 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
OSCR Stock 12 Month Forecast
Average Price Target
$16.06
▼(-11.56% Downside)
| Highest Price Target$25.00 | Average Price Target$16.06 | Lowest Price Target$11.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Piper Sandler
$13→$25
Buy
37.67%
Upside
Upgraded
11/26/25
Wells Fargo
$14→$11
Sell
-39.43%
Downside
Reiterated
11/13/25
Cautious Outlook on Oscar Health: Sell Rating Amid Uncertain Profitability and Market DynamicsWe see OSCR as a clear share gainer in 2026, making it harder to underwrite MLR improvement. PT to $11 on lower odds for enhanced subsidy extension. 3Q25 Results. MLR was roughly in-line with expectations, as an incremental true-up risk adjustment payable was offset by favorable development (both prior year and current year). OSCR reiterated guidance but noted that it expected to be towards the low-end of the revenue range due to the risk adjustment revision. We now see the jump-off point for EBITDA as below the guidance range because of favorable development. Changes to Model. Our analysis of pricing and landscape file suggest that OSCR will gain market share in 2026. We now assume enrollment is only down MSD / HSD% in 2026 while the market shrinks 35%.
UBS
$11→$12
Sell
-33.92%
Downside
Reiterated
11/07/25
Barclays
$11→$13
Sell
-28.41%
Downside
Reiterated
11/07/25
Goldman Sachs
$19.29
Hold
6.22%
Upside
Initiated
10/14/25
Robert W. Baird
―
Hold
―
Reiterated
08/14/25
Bank of America Securities
$11
Sell
-39.43%
Downside
Reiterated
08/06/25
Jefferies
$9→$8
Sell
-55.95%
Downside
Reiterated
07/23/25
Raymond James
―
Hold
―
Downgraded
06/24/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Piper Sandler
$13→$25
Buy
37.67%
Upside
Upgraded
11/26/25
Wells Fargo
$14→$11
Sell
-39.43%
Downside
Reiterated
11/13/25
Cautious Outlook on Oscar Health: Sell Rating Amid Uncertain Profitability and Market DynamicsWe see OSCR as a clear share gainer in 2026, making it harder to underwrite MLR improvement. PT to $11 on lower odds for enhanced subsidy extension. 3Q25 Results. MLR was roughly in-line with expectations, as an incremental true-up risk adjustment payable was offset by favorable development (both prior year and current year). OSCR reiterated guidance but noted that it expected to be towards the low-end of the revenue range due to the risk adjustment revision. We now see the jump-off point for EBITDA as below the guidance range because of favorable development. Changes to Model. Our analysis of pricing and landscape file suggest that OSCR will gain market share in 2026. We now assume enrollment is only down MSD / HSD% in 2026 while the market shrinks 35%.
UBS
$11→$12
Sell
-33.92%
Downside
Reiterated
11/07/25
Barclays
$11→$13
Sell
-28.41%
Downside
Reiterated
11/07/25
Goldman Sachs
$19.29
Hold
6.22%
Upside
Initiated
10/14/25
Robert W. Baird
―
Hold
―
Reiterated
08/14/25
Bank of America Securities
$11
Sell
-39.43%
Downside
Reiterated
08/06/25
Jefferies
$9→$8
Sell
-55.95%
Downside
Reiterated
07/23/25
Raymond James
―
Hold
―
Downgraded
06/24/25
Best Analysts Covering Oscar Health
1 Month
xxx
Success Rate
7/20 ratings generated profit
Average Return
-7.32%
reiterated a xxx
rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 35.00% of your transactions generating a profit, with an average return of -7.32% per trade.
3 Months
xxx
Success Rate
4/8 ratings generated profit
Average Return
-6.25%
reiterated a xxx
rating 21 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -6.25% per trade.
1 Year
Success Rate
5/8 ratings generated profit
Average Return
+53.77%
reiterated a sell rating 21 days ago
Copying Jonathan Yong's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +53.77% per trade.
2 Years
xxx
Success Rate
6/8 ratings generated profit
Average Return
+50.61%
reiterated a xxx
rating 21 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +50.61% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
OSCR Analyst Recommendation Trends
Rating
Jul 25
Aug 25
Sep 25
Oct 25
Nov 25
Strong Buy
0
0
0
0
0
Buy
13
11
6
1
1
Hold
9
12
10
8
7
Sell
9
12
13
7
5
Strong Sell
0
0
0
0
0
total
31
35
29
16
13
Each month's total comprises the sum of three months' worth of ratings.
OSCR Financial Forecast
OSCR Stock Forecast FAQ
What is OSCR’s average 12-month price target, according to analysts?
Based on analyst ratings, Oscar Health’s 12-month average price target is 16.06.
What is OSCR’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for OSCR, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is OSCR a Buy, Sell or Hold?
Oscar Health has a consensus rating of Moderate Sell which is based on 1 buy ratings, 1 hold ratings and 3 sell ratings.
What is Oscar Health’s price target?
The average price target for Oscar Health is 16.06. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $25.00 ,the lowest forecast is $11.00. The average price target represents -11.56% Decrease from the current price of $18.16.
The highest analyst price target is $25.00 ,the lowest forecast is $11.00. The average price target represents -11.56% Decrease from the current price of $18.16.
What do analysts say about Oscar Health?
Oscar Health’s analyst rating consensus is a Moderate Sell. This is based on the ratings of 5 Wall Streets Analysts.
How can I buy shares of OSCR?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.